Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Guardant Health gets EU CDx approval for Guardant360 CDx
Guardant Health received CE-marking for Guardant360 CDx in Europe as a companion diagnostic to identify ER+, HER2- advanced breast cancer patients for AstraZeneca’s camizestrant, after prior approvals in the U.S. and Japan.